ESC 365 - The new treatment pathway for hyperkalaemia.

Open Access

The new treatment pathway for hyperkalaemia.

Session: Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)

Topic: Antiarrhythmic drugs

Speaker: Doctor M. Kosiborod (Kansas City, US)

Sponsored by AstraZeneca

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

55 presentations

9 followers

3 more presentations in this session

Chair’s introduction - Lighting the way: a new path to manage hyperkalaemia.

Speaker: Professor L. Lund (Stockholm, SE)

Shedding light on the risk of moderate hyperkalaemia.

Speaker: Professor G. Rosano (London, GB)

Panel Q&A - Discussion - Lighting the way: a new path to manage hyperkalaemia.

Speaker: Professor L. Lund (Stockholm, SE) Professor G. Rosano (London, GB) Doctor M. Kosiborod (Kansas City, US)

Access the full session

Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)

Speakers: Doctor M. Kosiborod, Professor L. Lund, Professor G. Rosano, Professor L. Lund, Professor G. Rosano...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources